The vast majority of chronic and recurrent bacterial diseases are attributed to the presence of a recalcitrant biofilm that contributes significantly to pathogenesis. As such. these diseases will require an innovative therapeutic approach. We targeted DNABII proteins. https://www.opheliasmuse.com/